Neuropediatrics 2000; 31(4): 190-194
DOI: 10.1055/s-2000-7461
Original Article

Georg Thieme Verlag Stuttgart · New York

Huntington Disease in Children: Genotype-Phenotype Correlation

Astrid Rasmussen1 , R. Macias1 , Petra Yescas1 , Adriana Ochoa1 , G. Davila2 , Elisa Alonso1
  • 1 Department of Neurogenetics, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Mexico City, Mexico
  • 2 Department of Neurology, Instituto Nacional de Pediatria, Mexico City, Mexico
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Huntington disease is a neurodegenerative disorder of adulthood; however, a subset of early-onset patients exists, representing 1 % of all HD patients. We reviewed a population of 155 HD-families to determine the frequency, molecular and clinical characteristics of children with an onset before the age of 10 years.

In each case, a neurological evaluation was performed as well as molecular detection of the expanded CAG triplet in the affected child and both parents. The family history was also reviewed and updated.

Seven children (1.92 %) had onset of symptoms before the age of 10, two of them were dead by the time of the study. Large CAG expansions with intergenerational instability were identified, and in one case the child's allele was almost three times larger than the allele of the asymptomatic transmitting father, a situation reported only once before. Clinically, they showed preponderance of rigidity, seizures, learning disabilities and a rapid course of the disease. We attempted to use UHDRS. However, consistent results could not be obtained, suggesting that the scale should be revised for use in juvenile cases.

HD should be considered in the differential diagnosis of neurodegenerative diseases in children, even in the absence of a positive family history.

References

  • 1 Adams R D, Victor M. Principles of Neurology. 6th ed., Chapter 4. New York; Mc Graw Hill 1998: 68-77
  • 2 Alonso M E, Yescas P, Cisneros B, Martínez C, Silva G, Ochoa A. et al . Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population.  Clin Genet. 1997;  51 225-230
  • 3 Ashizawa T, Wong L-JC, Richards C S, Caskey C T, Jankovic J. CAG repeat size and clinical presentation in Huntington's disease.  Neurology. 1994;  44 1137-1143
  • 4 Brandt J, Bylsma F W, Gross R, Stine O C, Ranen N, Ross C A. Trinucleotide repeat length and clinical progression in Huntington's disease.  Neurology. 1996;  46 527-531
  • 5 Carpenter N. Genetic anticipation. Expanding tandem repeats.  Neurol Clin North [Am]. 1994;  12 683-697
  • 6 Coles R, Leggo J, Rubinsztein D C. Analysis of the 5' upstream sequence of the Huntington's disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD.  J Med Genet. 1997;  34 371-374
  • 7 Craufurd D, Dodge A. Mutation size and age at onset in Huntington's disease.  J Med Genet. 1993;  30 1008-1011
  • 8 De Rooij K E, De Koning Gans P AM, Skraastad M I, Belfroid R DM, Vegter-Van der Vlis M, Roos R AC. et al . Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.  J Med Genet. 1993;  30 996-1002
  • 9 Fisher M, Sargent J, Drachman D. Familial inverted choreoathetosis.  Neurology. 1979;  29 1627-1631
  • 10 Goebel H H, Heipertz R, Scholz W, Iqbal K, Tellez-Nagel Y. Juvenile Huntington chorea: Clinical, ultrastructural and biochemical studies.  Neurology. 1978;  28 23-31
  • 11 Hansotia P, Cleeland C S, Chun R WM. Juvenile Huntington's chorea.  Neurology. 1968;  18 217-224
  • 12 Haslam R HA, Curry B, Johns R. Infantile Huntington's disease.  Can J Neurol Sci. 1983;  10 200-203
  • 13 Holinski-Feder E, Baldwin-Jedele K, Hörtnagel K, Albert A, Meindl A, Trenkwalder C. Large intergenerational variation in age of onset in two young patients with Huntington's disease presenting as dyskinesia.  Pediatrics. 1997;  100 896-898
  • 14 Huntington Study Group . Unified Huntington's Disease Rating Scale: Reliability and consistency.  Mov Disord. 1996;  11 136-142
  • 15 Jervis G A. Huntington's chorea in childhood.  Arch Neurol. 1963;  9 244-257
  • 16 MacMillan J C, Snell R G, Tyler A, Houlihan G D, Fenton I, Cheadle J P. et al . Molecular analysis and clinical correlations of the Huntington's disease mutation.  Lancet. 1993;  342 954-958
  • 17 Markham C H, Knox W J. Observations on Huntington's chorea in childhood.  J Pediatr. 1965;  67 46
  • 18 Nance M A, and the Huntington Disease Genetic Testing Group U S. Genetic testing of children at risk for Huntington's disease.  Neurology. 1997;  49 1048-1053
  • 19 Nance M A, Mathias-Hagen V, Breningstall G, Wick M J, McGlennen R C. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.  Neurology. 1999;  52 392-394
  • 20 Oliver J, Dewhurst K. Childhood and adolescent forms of Huntington's disease.  J Neurol Neurosurg Psych. 1969;  32 455-459
  • 21 Rubinsztein D C, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E. et al . Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.  Proc Natl Acad Sci USA. 1997;  94 3872-3876
  • 22 Siesling S, Vegter-van der Vlis M, Roos R AC. Juvenile Huntington disease in the Netherlands.  Pediatr Neurol. 1997;  17 37-43
  • 23 Simpson S A, Davidson M J, Barron L H. Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.  J Med Genet. 1993;  30 1014-1017
  • 24 Squitieri F, Andrew S E, Goldberg Y P, Kremer B, Spence N, Zeisler J. et al . DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.  Hum Molec Genet. 1994;  3 2103-2114
  • 25 Storey E, Beal M F. Neurochemical substrates of rigidity and chorea in Huntington's disease.  Brain. 1993;  116 1201-1222
  • 26 Telenius H, Kremer H PH, Theilmann J, Andrew S E, Almqvist E, Anvret M. et al . Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent.  Hum Molec Genetics. 1993;  2 1535-1540
  • 27 Trottier Y, Biancalana V, Mandel J L. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.  J Med Genet. 1994;  31 377-382
  • 28 van Dijk J G, van der Velde E A, Roos R AC, Bruyn G W. Juvenile Huntington disease.  Hum Genet. 1986;  73 235-239
  • 29 Wellington C L, Brinkman R R, O'Kusky J R, Hayden M R. Toward understanding the molecular pathology of Huntington's disease.  Brain Pathol. 1997;  7 979-1002
  • 30 Went L N, Vegter-Van der Vlis M, Bruyn G W. Parental transmission in Huntington's disease.  Lancet. 1984;  1(8386) 1100-1102

Dr. Astrid Rasmussen

Department of Neurogenetics Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

Insurgentes Sur 3877, Col. La Fama

CP 14269. Mexico D. F.

Mexico

Email: E-mail: astridra@data.net.mx

    >